21 Jan 2013 16:03
ο»Ώ
Β
Β
Β
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
Β
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Consort Medical plc |
Β
2 Reason for the notification (please tick the appropriate box or boxes): | ||
Β An acquisition or disposal of voting rights | X | |
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||
Β An event changing the breakdown of voting rights | ||
Β Other (please specify): | ||
Β
3. Full name of person(s) subject to the notification obligation: Β | Β Aviva plc and its subsidiaries |
4. Full name of shareholder(s) (if different from 3.): Β | Β Registered Holder: Β BNY (Nominees) Limited 15,482* BNY Norwich Union Nominees Ltd 164,963* Chase (GA Group) Nominees Ltd 1,026,647* Chase Nominees Limited 32,337* Vidacos Nominees Limited 11,802* Chase Nominees Ltd 4,930 Vidacos Nominees Ltd 227,941
* denotes direct interest Β |
5. Date of the transaction and date on which the threshold is crossed or reached: | 17 January 2013 |
6. Date on which issuer notified: Β | 18 January 2013 |
7. Threshold(s) that is/are crossed or reached: Β |
Β
8. Notified details: | |||||||
A: Voting rights attached to shares Β | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||
Direct | Direct | Indirect | Direct | Indirect | |||
Β Β Β GB0000946276 | Β 1,177,609 | Β 1,177,609 | Β 1,484,102 | Β 1,251,231 | 232,871 | 4.28% | 0.8% |
Β
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction Β | ||||
Type of financialinstrument | Expirationdate | Exercise/ConversionPeriod | Number of votingrights that may beacquired if theinstrument isexercised/ converted. Β | % of votingrights |
Β
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction Β | ||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights Β | |
Nominal | Delta Β | |||||
Β
Total (A+B+C) Β | |
Number of voting rights | Percentage of voting rights |
Β 1,484,102 | 5.08% |
Β
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: |
Β The voting rights are managed and controlled by Aviva Investors Global Services Limited with the following chain of controlled undertakings: Β Aviva Investors Global Services Limited: Β·; Aviva plc (Parent Company) Β·; Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) Β·; Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Plc) Β·; Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Β |
Β
Proxy Voting: Β | |
10. Name of the proxy holder: Β | Β See Section 4 |
11. Number of voting rights proxy holder will cease to hold: Β | |
12. Date on which proxy holder will cease to hold voting rights: Β | |
Β
13. Additional information: Β | Figures are based on a total number of voting rights of 29,201,914 as per TVR announcement on 3 January 2013 |
14. Contact name: Β | John Slater Company Secretary |
15. Contact telephone number: Β | 01442 867920 |
Β
Follow the stocks